1 recruiting. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Recruiting 1 |
Follow Efficacy: new trials by email Literature Review of Efficacy trials Research Report on Efficacy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis Human amniotic-derived mesenchymal stem cells - Chronic Kidney Diseases, Calciphylaxis | Early Phase 1 | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 9 | 2018-09-17 | 2026-03-04 |
Calciphylaxis (1) · Rare Diseases (1) · Renal Insufficiency, Chronic (1)
Calcinosis (1) · Calcium Metabolism Disorders (1) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Urogenital Diseases (1) · Urologic Diseases (1)
The First Affiliated Hospital with Nanjing Medical University (1)
China (1)
Jiayin Liu, Professor (1) · Lianju Qin (1) · Ningning Wang, Professor (1)
PMID 35142858, PMID 35412950, PMID 39234636, PMID 40097288, PMID 40518559